drugset / Trial / NCT03825718
A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
NaSingle-groupOpen-labelTreatment
Summary
The study is an early, open, single-centered trial.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2020-09-01
- Completion
- 2020-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GC007F | Cell therapy | 60000 cells/kg | — |
| Subject | GC007F | Cell therapy | 2e+06 cells/kg | — |